MiniMed Group, Inc. Common Stock

Price Chart

Risk-Adjusted Performance

MiniMed Group, Inc. Common Stock (MMED) Price Performance

MiniMed Group, Inc. Common Stock (MMED) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at $14.44, up 3.00% from the previous close.

Over the past year, MMED has traded between a low of $13.20 and a high of $20.00. The stock has lost 27.8% over this period. It is currently 27.8% below its 52-week high.

MiniMed Group, Inc. Common Stock has a market capitalization of $4.58B.

About MiniMed Group, Inc. Common Stock

Minimed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, including insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera, or Guardian 4, and wraparound applications and services. Minimed Group, Inc. was founded in 1983 and is headquartered in Northridge, California. Minimed Group, Inc. operates as a subsidiary of Medtronic Global Holdings S.C.A.

Compare MiniMed Group, Inc. Common Stock

Side-by-side comparison against top Healthcare peers.